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Herpes simplex viruses infect a variety of cells in vitro. However, not all infected cells sustain a fully productive replication of these viruses.
We have shown that, in U937 monocytoid cells, herpes simplex virus 2 (HSV-2) causes a low-productive infection characterized by apoptosis as
cytopathic effect at a late stage of infection. This effect was associated with a down-regulation of the Bcl-2 protein. We therefore asked whether
destabilization of Bcl-2 expression could act as a limiting factor for the productive HSV-2 infection. We found that overexpression of Bcl-2 in
U937 cells dramatically increased the capability of these cells to sustain a fully productive infection, while protecting against apoptosis induced by
HSV-2. Overall, our data indicate that Bcl-2 expression acts as a regulator of HSV-2 replication.
© 2006 Elsevier Inc. All rights reserved.Keywords: Apoptosis; Bcl-2; Herpes simplex; Virus replication; Virus infectionIntroduction
Although herpes simplex viruses (HSVs) infect a variety of
human and nonhuman cell types, a post-entry restriction of
infection occurs frequently. As a consequence, not all cell types
potentially susceptible to HSVs can sustain fully productive
replication of the viruses (Roizman and Knipe, 2001). Among
these, lymphocytes, monocyte/macrophages and dendritic cells,
despite harboring specific receptors that allow HSV attachment
and entry, do not permit a full replication of the viruses. The
significance of this phenomenon and the mechanisms control-
ling restriction of HSV infection in different, potentially
susceptible cell types are poorly understood.
Full permissiveness to HSV infection is typically associated
with cytolysis through the necrotic route, while abortive or low-
productive HSV infection in immune cells is often associated
with induction of apoptosis (Raftery et al., 1999; Fleck et al.,⁎ Corresponding author. Fax: +39 090 392733.
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doi:10.1016/j.virol.2006.08.0011999; Bosnjak et al., 2005). In fact, during evolution HSVs have
selected redundant and apparently conflicting strategies to exert
a fine control on apoptosis (Goodkin et al., 2004). This is not
surprising as both herpes simplex virus type 1 (HSV-1) and
herpes simplex virus type 2 (HSV-2) harbor in their genomes
genes allowing them to cohabit with all the principle functions of
the host cellular apparatus. Various viral and cellular genes,
exerting a direct or indirect regulatory action on cell death during
HSV infection have been identified. Particularly, studies from
different groups proved that someHSV gene products play a role
in preventing apoptosis. Concerning HSV-1, these include γ1
34.5 protein, infected cell protein 4 (ICP4), infected cell protein
27 (ICP27), Us3 protein kinase, glycoprotein J, glycoprotein D
(gD) and a microRNA encoded by the latency-associated
transcript gene (Chou and Roizman, 1992; Leopardi and
Roizman, 1996; Aubert and Blaho, 1999; Munger et al., 2001;
Hagglung et al., 2002; Zhou et al., 2000; Zhou and Roizman,
2001; Jerome et al., 2001; Medici et al., 2003; Gupta et al.,
2006). Concerning HSV-2, the R1 protein kinase (ICP10 PK)
has been shown to block apoptosis (Perkins et al., 2002).
Regarding the cellular proteins which might potentially be
Fig. 1. Expression of viral gene cascade and in U937 and Vero cells infected by
HSV-2. Cells were infected at a multiplicity of infection (MOI) of 50 PFU/cell
(U937) or of 1 PFU/cell (Vero), respectively, with a “G” strain of HSV-2. At
various times following infection, total RNA from infected cells was extracted,
and 1.5 μg of RNA from U937 cells or 150 ng of RNA from Vero cells were
reverse-transcribed and amplified using specific primers spanning over internal
sequence of US1, UL39 and UL41 of HSV-2, respectively. PCR products were
resolved on 2% agarose gel. Lanes 2, 4, 6, 8, 10, 12 and 14: reverse transcriptase
was added to the reaction mixture. Lanes 3, 5, 7, 9, 11, 13 and 15: reverse
transcriptase was omitted from the reaction mixture. Lanes 2 and 3: 30 min.
Lanes 4 and 5: 60 min. Lanes 6 and 7: 90 min. Lanes 8 and 9: 3 h. Lanes 10 and
11: 5 h. Lanes 12 and 13: 7 h. Lanes 14 and 15: 9 h. Lane 16: PCR of DNA
extracted from mock-infected cells, used as a template for positive control. Lane
17: PCR without DNA template as a negative control for mock-infected cells.
Lane 18: PCR of DNA extracted from HSV-2-infected cells, used as a template
for positive control. Lane 19: PCR without DNA template, as a negative control
for HSV-2-infected cells. Lane 1: 1-kb plus DNA ladder. The positions of the
amplified products are also shown.
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infection, members of the Bcl-2 family seem interesting can-
didates. In fact, the US3 protein kinase of HSV-1 has been shown
to prevent apoptosis induced by different stimuli, through
interaction with BH3-only pro-apoptotic proteins (Munger and
Roizman, 2001; Cartier et al., 2003; Ogg et al., 2004).Moreover,
overexpression of Bcl-2 blocked apoptosis induced by a mutant
HSV-1 in a HEp-2 derived cell line and a retrovirus expression
vector encoding bcl-2 rendered HeLa cells resistant to the cyto-
pathic effect of HSV-1 derived vectors (Galvan et al., 2000;
Eling et al., 2000). In addition, wild type HSV-1 prevented
p38MAPK-dependent destabilization of Bcl-2 in permissive
cells (Zachos et al., 2001) and the HSV-2 R1 protein kinase
increased the stabilization of Bcl-2 in cultured hippocampal
neurons (Perkins et al., 2003). Finally, we demonstrated that the
down-regulation of Bcl-2 was associated with induction of
apoptosis by wild type HSV-2, as a late event occurring follow-
ing restricted infection of U937 monocytoid cells Mastino et al.,
1997). However, all these studies focused on HSV/Bcl-2
interaction in regulating apoptosis and not in controlling HSV
replication.
We therefore asked whether destabilization of Bcl-2
expression could act as a major restriction factor for productive
infection by HSV-2. Indeed, Bcl-2 overexpression in U937 cells
allowed fully productive HSV-2 replication, while preventing
apoptosis. Our results suggest that Bcl-2 expression could play
a role in controlling the permissiveness/restriction state in HSV-
2-infected cells.
Results
Restriction state in HSV-2-infected U937 cells is not due to a
dysregulation in expression of the viral gene cascade
Infection of U937 cells by HSV-2 leads to the release of about
100 times less infectious particles than that released by fully
permissive Vero cells (Mastino et al., 1997). We therefore asked
whether this was due to an alteration in the expression of the
HSV-2 gene cascade, during the replication cycle, in this cellular
system. U937 cells were infected at a high multiplicity of
infection (MOI) and, at various time points, total RNA was
extracted from infected cells. The RNA was then reverse-
transcribed and amplified using specific primers spanning over
internal sequence of three representative genes for α, β and γ
genes of HSV-2. RNA for the representative α gene product
ICP22 was well detectable at 30 min after inoculum removal, i.e.
at 90 min after first exposure to virus, after which it was
practically stable (Fig. 1, upper panel). Maximal expression of
RNA for ICP10/RR1 β gene product occurred at 3–5 h while
that of the vhs γ gene product was further delayed (Fig. 1A).
Contamination with genomic DNA was excluded by lack of
PCR amplification products in the absence of reverse-transcrip-
tion. Detection of RNA for vhs by reverse-transcriptase PCR as
early as 90 min after exposure to virus, could be presumably
ascribed also to the capacity of HSV to carry functional RNA
in their viral particles, as demonstrated by some of us
(Sciortino et al., 2002). A similar profile in the kinetics ofexpression of the same genes was observed in HSV-2 permissive
Vero cells, infected at a lowMOI (Fig. 1, lower panel) andHEp-2
cells (data not shown). From these experiments, we concluded
that during the first phase of HSV-2 infection in U937 cells there
was no block in the classical viral gene cascade and that the
limited production of HSV-2 viral particles in these cells could
be due to different events.
Bcl-2 overexpression protects U937 cells from HSV-2-induced
apoptosis
We have shown that coincident with induction of MOI and
time-dependent apoptosis, HSV-2 causes the down-modulation
of Bcl-2 expression in U937 cells at a late stage of infection
(Mastino et al., 1997). This suggests that the survival factor Bcl-
138 M.T. Sciortino et al. / Virology 356 (2006) 136–1462 may play a role in regulating apoptosis caused by HSV-2.
Given this possibility, we asked whether maintenance of high
level Bcl-2 expression affects viability in U937 cells infected by
HSV-2. We therefore used U937 cells stably overexpressing
murine Bcl-2 (U937Bcl-2) (Borner, 1996) and compared them
with cells carrying the expression vector alone (U937pMEP).
Murine Bcl-2 expression was confirmed by Western blot
analysis, using a mAb specific for murine Bcl-2 which does
not cross-react with human Bcl-2 (Fig. 2A). To control
functionality of overexpressed Bcl-2, we exposed U937pMEP
and U937Bcl-2 cells to etoposide, an agonist anti-Fas antibody
or high dose TNF. Overexpression of Bcl-2 rendered U937Bcl-2
cells highly resistant to all three apoptotic stimuli (Fig. 2B).
Kinetic andMOI-dependency experiments proved that wild type
U937 cells and U937pMEP cells were equally susceptible to
HSV-2 infection, as detected by percentage of cells expressing
virus-specific proteins using IFA or by virus yield titrated by
plaque assay in Vero cells (data not shown). We then tested thecapacity of U937Bcl-2 cells to resist apoptosis induced by HSV-
2 at a high MOI. Flow cytometry analysis following propidium
iodide staining at 72 h post infection demonstrated that while
HSV-2-infected U937pMEP samples showed remarkable
amounts of hypodiploid nuclei (Fig. 2C, upper right panel,
M2), only a few such nuclei were detected in samples fromHSV-
2-infected U937Bcl-2 cells (Fig. 2C, lower right panel, M2).
Similar results were obtained when apoptosis was detected by
morphological analysis following staining with acridine orange,
as shown in Fig. 2D that summarizes the time course of
apoptosis up to 72 h, in HSV-2-infected U937pMEP and
U937Bcl-2 cells (see also Supplementary material). Apoptosis
of mock-infected U937pMEP as well as of U937Bcl-2 cells, in
the same time course, was consistently low, showing a very
narrow range of variation (minimum, 2.2%, maximum 5.3%).
These experiments clearly show that Bcl-2 effectively protects
U937 cells from HSV-2-induced apoptosis. Moreover, this
protection persisted for the entire duration of the experiments, as
HSV-2-infected U937Bcl-2 cells abruptly disintegrated starting
from 6–7 days after infection, without evident signs of apoptosis
(data not shown).
Bcl-2 overexpression overcomes the incapability of U937 cells
to sustain a fully productive infection by HSV-2
We then wanted to know whether the death protection of
U937 cells by Bcl-2 was associated with any changes in theFig. 2. Bcl-2 overexpression protects U937 cells from HSV-2-induced apoptosis.
(A) Ectopic expression of the murine bcl-2 gene in U937 cells determined by
Western blotting analysis. Proteins extracted from cells stably transfected with
the expression vector alone (U937pMEP) or with murine Bcl-2 (U937Bcl-2) by
lysis buffer were separated by SDS-PAGE electrophoresis, transferred to
membrane, immunoblotted with a mAb specific for murine Bcl-2 which does
not cross react with human Bcl-2 and visualized by ECL. The molecular weight
is also shown. (B) Control transfectants (U937pMEP) or murine-Bcl-2-
expressing transfectants (U937Bcl-2) were treated with etoposide, an agonist
anti-Fas antibody (antiFas) or tumor necrosis factor (TNF) and incubated for
18 h in 1% FCS medium. Apoptosis was then evaluated using fluorescence
microscopy by calculating the percentage of cells showing the nuclear
morphology of apoptosis after staining with acridine orange. Results are
expressed as mean values±SD obtained from three replicate cultures.
Comparison between corresponding groups using the Student's t test for
independent samples was highly significant (p<0.001). (C) Apoptosis,
evaluated using flow cytometry analysis of hypodiploid nuclei isolated and
stained with a hypotonic solution containing detergent and propidium iodide, in
control transfectants (U937pMEP) or murine-Bcl-2-expressing transfectants
(U937Bcl-2) mock-infected or infected with HSV-2 at a MOI of 50 PFU/cell.
Apoptosis was detected 72 h after infection. The lines designated as M1, M2 and
M3, indicate the boundaries among the peaks of diploid (M3), hypodiploid (M2)
nuclei and presumably of debris (M1), which were arbitrarily set on untreated
samples and maintained for all other samples. Percentages of hypodiploid (M2)
nuclei are reported in the cytograms. (D) Apoptosis evaluated using
fluorescence microscopy by calculating the percentage of cells showing the
nuclear morphology of apoptosis after staining with acridine orange, in control
transfectants (U937pMEP) or murine-Bcl-2-expressing transfectants (U937Bcl-
2) infected with HSV-2 at an MOI of 50 PFU/cell, at 24 h, 48 h and 72 h after
infection. Results are expressed as mean values±SD obtained from three
replicate cultures in one of the three experiments performed with similar results.
Comparison of differences among the groups using the multiple comparison
Bonferroni test was as follows: U937pMEP vs. U937Bcl-2, at all corresponding
times, p<0.001; U937pMEP, 24 h vs. 48 h, NS; U937pMEP, 24 h vs. 72 h and
48 h vs. 72 h, p<0.001; U937Bcl-2, among all times, NS.
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infectivity of HSV-2 in U937Bcl-2 and U937pMEP cells by
simultaneously staining the cells with a mAb specific for HSV-
gD and with a mAb specific for endogenous human Bcl-2. No
HSV-gD expression was detected, as expected, in mock-
infected cells. In HSV-2-infected cells, flow cytometry analysis
showed a higher expression of HSV-gD in U937Bcl-2 cells in
comparison with U937pMEP control cells, particularly at 48 h
after infection (Fig. 3, FL2-H). Moreover, control U937pMEP
cells, unlike murine-Bcl-2 overexpressing cells, showed a
decrease in the expression of endogenous Bcl-2 with the
ongoing of the infection (Fig. 3, FL1-H). Interestingly, double
fluorescence analysis clearly demonstrated a strict, direct
correlation between endogenous Bcl-2 levels and the ability
to support HSV-2 replication, as measured by gD protein
expression, at single cell level. In fact, dot-plot analysis showed
that both U937Bcl-2 and U937pMEP cells infected by HSV-2
were diagonally distributed in the cytograms, following Bcl-2/
gD double-staining (Fig. 3, Bcl-2/gD). In addition, consistentFig. 3. Single- or two-color flow cytometry analysis of glycoprotein D and Bcl-2 i
transfectants (U937pMEP) or murine-Bcl-2-expressing transfectants (U937Bcl-2) we
48 h after infection, cells were fixed in 4% paraformaldehyde in PBS, permeabilized in
mAb (FL2-H). Cells were then incubated with phycoerythrin-conjugated goat anti-m
fluorescein isothiocyanate-conjugated anti-human Bcl-2 mAb (FL1-H). Negative c
phycoerythrin-conjugated secondary antibody only and, successively, with a fluoresc
color or two-color analyses of the same samples. Shaded histograms in single-color a
boundaries between negative and positive cells which were arbitrarily set for sampl
corresponding Bcl-2/gD stained samples.with the above reported results, both Bcl-2 and gD were less
expressed in U937pMEP than in U937Bcl-2 cells. Subse-
quently, we measured infectious virus from HSV-2-infected
U937Bcl-2 cells and U937pMEP cells as assayed by plaque
formation in permissive Vero cells. Fig. 4A shows the time
course of virus yield following exposure to HSV-2 for 1 h. Both
U937pMEP and U937Bcl-2 cells clearly showed a progressive
increase in virus yield during the first 24 h. Moreover, at the
same time point, the difference of virus titer between U937Bcl-2
and U937pMEP control cells was highly statistically signifi-
cant, and this difference persisted also at 48 h and 72 h after
infection (Fig. 4A). The continuously active replication of HSV-
2 in U937Bcl-2 cells was confirmed by a semi-quantitative RT-
PCR assay to detect the expression of the UL41 γ gene of HSV-
2. In this assay, total RNA from infected or control cells was
reverse-transcribed and cDNAwas successively amplified using
a reaction mix containing primer pairs specific for UL41
together with primer pairs specific for ribosomal 18S RNA, as a
reference marker, before visualization of the PCR products onn control and mBcl-2-overexpressing transfectants infected by HSV-2. Control
re mock-infected or infected with HSV-2 at a MOI of 50 PFU/cell. At 24 h and
0.1% Triton X-100 in PBS with 0.1% FCS and incubated with a specific anti-gD
ouse IgG, as a secondary antibody for gD detection, and successively with the
ontrol staining was carried out by incubating control samples firstly with the
ein-conjugated mouse IgG isotype control antibody. Results are shown as single-
nalysis represent control staining. Dashed lines in two-color analysis indicate the
es subjected to negative control staining (not shown) and maintained in all the
Fig. 4. Kinetic of virus yield and relative-quantitative PCR analysis in control
and mBcl-2-overexpressing transfectants infected with HSV-2. (A) Total virus
yield (lines) was titrated by plaque standard assay in Vero cells at 3 h, 24 h, 48 h
and 72 h following infection of control transfectants (U937pMEP) or murine-
Bcl-2-expressing transfectants (U937Bcl-2) with HSV-2 at a MOI of 50 PFU/
cell. Results are expressed as mean values±SD obtained from three independent
titrations. Comparison of differences among the groups using the multiple
comparison Bonferroni test, was as follows: U937pMEP vs. U937Bcl-2, at 3 h,
NS; U937pMEP vs. U937Bcl-2, at all other corresponding times, p<0.001;
U937pMEP, 3 h vs. all other times, p<0.001; U937pMEP, among all times less
3 h, NS; U937Bcl-2, 3 h vs. all other times, p<0.001; U937Bcl-2, among all
times less 3 h, NS; (B) relative-quantitative PCR analysis was carried out with
the aid of the QuantumRNA 18S, control transfectants (U937pMEP) or murine-
Bcl-2-expressing transfectants (U937Bcl-2) were collected at different times
after infection with HSV-2, and total RNA was extracted. Samples were then
processed to eliminate possible viral DNA contamination and reverse-
transcribed by random primers. The UL41 gene of HSV-2 and the 18S
sequence, as an internal standard, were then amplified by PCR using specific
primers. PCR products were resolved on 2% agarose gel. Lanes 2, 4, 6, 8, 10 and
12: U937Bcl-2 cells. Lanes 3, 5, 7, 9, 11 and 13: U937pMEP cells. Lanes 2 and
3: mock-infected. Lanes 4–13: cells infected with HSV-2. Lanes 1: 1-kb plus
DNA ladder. The positions of the amplified products are also shown. (C)
Densitometric analysis of PCR products shown in panel B, expressed as relative
optical density following normalization with 18S.
Fig. 5. Transmission electron microscopy of control transfectants (U937pMEP)
or murine-Bcl-2-expressing transfectants (U937Bcl-2). (A) Morphological
feature of control U937pMEP cells at the beginning of infection. (B)
Morphological feature of U937mBcl-2 cells at the beginning of infection. (C)
Morphological feature of control U937pMEP cells 24 h after infection. (D)
Morphological feature of U937Bcl-2 cells 24 h after infection. Arrows point to
large masses of naked capsids inside the nucleus located beneath the inner side
of the nuclear membrane. n: nucleus. Scale bar: 2 μm.
140 M.T. Sciortino et al. / Virology 356 (2006) 136–146agarose gel. As shown in Figs. 4B and C the UL41 gene
transcripts remained highly detectable with increasing time of
infection in U937Bcl-2 cells. Conversely, densitometric analy-
sis demonstrated that UL41 transcript progressively decreased
in U937pMEP starting from day 3 following infection (Fig. 4C).
These results indicate that the pro-survival effect of Bcl-2
overexpression was associated with a remarkable prolongation
of the capacity of U937 cells to sustain active HSV-2
replication. In contrast, in control U937pMEP cells, the
production of infectious viral progeny was already impaired at24 h after infection (Fig. 4A), obviously before appearance of
massive HSV-2-induced apoptosis (Fig. 2C).
We also detected important changes in the pattern of HSV-2
replication between U937pMEP and U937Bcl-2 cells by
electron microscopy analysis. In permissive cells, herpes
simplex viruses replicate in the nucleus, where typical replica-
tion compartments are formed and profound nuclear changes
occur (Roizman and Knipe, 2001; Monier et al., 2000). Both
control U937pMEP cells andmBcl-2-overexpressing U937 cells
showed a similar morphology at the beginning of infection (Figs.
5A and B, respectively). Particularly, no differences in
mitochondrial structure (Figs. 6A and A1, respectively) or in
morphology of viral attachment and entry (Figs. 6B and B1,
respectively), were observed. However, at 24 h following in-
fection U937pMEP cells started to exhibit morphological
changes at both nuclear (chromatin margination, picnotic and
deformed nuclei, Fig. 5C) and mitochondrial levels (Fig. 6C).
Moreover, naked capsids with various morphologies, including
well recognizable empty capsids, were detectable in the nuclei of
these cells (Fig. 6D, arrow). At the same time after infection, also
U937Bcl-2 cells showed chromatin margination, but they
maintained cellular and nuclear integrity (Fig. 5D). Furthermore,
most of the mBcl-2-overexpressing cells displayed large masses
of naked capsids in nuclear compartments located in the inner
margins of the nuclear membrane (Figs. 5D and 6D1, arrows).
These formations had the typical features of paracrystalline,
Fig. 6. Details of transmission electron microscopy of control transfectants (U937pMEP) or murine-Bcl-2-expressing transfectants (mBcl-2) infected with HSV-2.
(A, B) Micrographs showing ultrastructural details of control U937pMEP cells at the beginning of infection. (A1, B1) Micrographs showing ultrastructural details of
overexpressing U937Bcl-2 cells at the beginning of infection. (C, D) Micrographs showing ultrastructural details of control U937pMEP cells at 24 h after infection.
(C1, D1) Micrographs showing ultrastructural details of overexpressing U937Bcl-2 cells at 24 h after infection. (E, F) Micrographs showing ultrastructural details of
control U937pMEP cells at 48 h after infection. (E1, F1) Micrographs showing ultrastructural details of overexpressing U937Bcl-2 cells at 48 h after infection.
Arrows point to naked capsids, clustered (D, D1, E1, F1) or scattered (F) inside the nucleus; double pointed arrows point to viral particles enveloped in cytoplasmic
vesicles. Arrowhead in the upper inset in E1, points to enveloped capsid apparently budding at nuclear membrane level m: mitochondrion; n: nucleus. Scale bars: A,
A1, C, C1, D, D1, E, E1, F and F1: 500 nm. B, B1 and details in the insets: 150 nm.
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productive HSV infection in permissive cells. Moreover,
presumable tegumentation and envelopment of viral particles
in the cytoplasmic compartments were observed frequently in
U937Bcl-2 cells (Fig. 6C1) and very rarely in U937pMEP cells.
At 48 h after infection, U937pMEP cells were remarkably
damaged and showed clear signs of cytoplasmic disintegration
(Fig. 6E). Single viral particles with various morphologies, all
lacking an envelope, were still detectable scattered throughout
the nucleus of some cells (Fig. 6F, arrows). Conversely, at this
time, most of the U937mBcl-2 cells remained intact. They
continued to show the typical morphology of HSV actively
producing cells, with regular aggregates of naked capsids close
to the inner leaflet of the nuclear membrane (Figs. 6E1 and F1,
arrows; see also the insets). In summary, these results show thatthe morphology of U937Bcl-2 cells following HSV-2 infection
remarkably resembled that classically described for HSV-
infected fully permissive cells. Thus, prolonged overexpression
of Bcl-2 apparently abrogated the post-transcriptional restriction
of U937 cells to HSV-2 infection.
Inhibition of HSV-2-induced apoptosis by the pan-caspase
inhibitor Z-VAD-FMK does not enhance virus production
We also wanted to verify whether inhibition of HSV-2-
induced apoptosis by another mechanism could enhance virus
production, similarly to what happened in murine-Bcl-2 over-
expressing cells. To this purpose, we treated wild type U937
cells with the synthetic, cell-permeable, non-cleavable peptide
analog Z-VAD-FMK to irreversibly inhibit protease activity
142 M.T. Sciortino et al. / Virology 356 (2006) 136–146following infection with HSV-2 at a MOI of 50 PFU/cell. This
peptide acts as a general caspase inhibitor. As shown in Fig. 7A,
Z-VAD-FMK significantly reduced apoptosis of infected
cultures, in comparison with control-treated cultures. This
effect was particularly evident at 72 h after infection. However,
Fig. 7B shows that treatment with Z-VAD-FMK, while almost
completely blocked apoptosis induced by HSV-2 in U937 cells,
did not substantially alter virus production as measured by
plaque assay.
Discussion
Activation of the apoptotic pathway represents a first line,
innate defense to restrict viral replication (Barber, 2001). On the
other hand, control of the apoptotic machinery of infected cells,
is one of the most powerful mechanisms for viruses to disarm
non-specific resistance of the host (Benedict et al., 2002; Hay
and Kannourakis, 2002).
In this context, several authors have focused their attention on
Bcl-2, the founding member of a family of proteins playing
pivotal roles in apoptosis (Borner, 2003). In fact, this anti-
apoptotic protein could act as a key regulator in the balance
between cellular apoptotic response and viral strategies of
immune evasion, therefore largely influencing the final outcome
of a viral infection. Related to this is the finding that various
human herpesviruses encode viral homologues of Bcl-2 in their
genomes (Hardwick and Bellows, 2003; Polster et al., 2004).
Such an evolutionary convergence, based on Bcl-2 mimicry,
suggests that maintenance of Bcl-2 functional activity seems to
be an important strategy for the ineffectiveness of this family of
viruses. However, Bcl-2 homologues have not been detected in
the genome of HSVs, nor have any experimental result
adequately explained the role of Bcl-2 expression in theFig. 7. Effect of caspase inhibition on apoptosis and on virus yield in U937 cells foll
added, at the concentration of 50 μM, to U937 cells infected with HSV-2 at a M
concentration daily. At different times after infection, apoptosis (left panel) and virus
HSV-2-infected cells treated with DMSO control diluent (HSV-2+DMSO) and in HS
was evaluated using fluorescence microscopy by calculating the percentage of cells s
Total virus yield was titrated by plaque standard assay in Vero cells. Results are expr
comparison of differences among the groups using the multiple comparison Bonferro
VAD-FMK vs. HSV-2+DMSO, at 24 h, NS; HSV-2+Z-VAD-FMK vs. HSV-2+DM
vs. 72 h and 48 h vs. 72 h, p<0.001; HSV-2+DMSO, among all times, p<0.001
differences among the groups using the multiple comparison Bonferroni test, was as f
VAD-FMK), at all times, NS; HSV-2, 24 h vs. 48 h and vs. 72 h, p<0.001; HSV-2, 4
+DMSO, 48 h vs. 72 h, NS; HSV-2+Z-VAD-FMK, 24 h vs. 48 h and vs. 72 h, p<infective cycle of these viruses. Nevertheless, observations
reported by various groups, using different experimental
models, including both HSV-1 and HSV-2, suggest a possible
function of Bcl-2 in preventing apoptosis during HSV infection
(Munger and Roizman, 2001; Cartier et al., 2003; Ogg et al.,
2004; Galvan et al., 2000; Eling et al., 2000; Zachos et al., 2001;
Perkins et al., 2003). Consistent with this hypothesis, we here
show that overexpression of Bcl-2 is sufficient to completely
interrupt the cascade of events leading to apoptosis in
monocytoid cells infected with wild type HSV-2. However,
the key new finding of our study was that U937 monocytoid
cells, usually unable to efficiently sustain HSV-2 replication,
became apparently fully permissive to the virus bymeans of Bcl-
2 overexpression. Thus, based on our results, we propose that
sustained Bcl-2 expression during HSV-2 infection not only
serves a role in promoting cell survival, but also augments HSV
replication, i.e. determines the permissiveness state of a cell for
HSV infection.
While our results clearly outline the importance of proto-
oncogene Bcl-2 expression in determining the host-cell
permissiveness to HSV-2 infection, they do not provide a
mechanistic explanation for the observed phenomenon. It
remains to be determined exactly how Bcl-2 affects HSV
replication in infected cells and how virus replication and
apoptosis are mechanistically linked. One possibility is that a
high level of Bcl-2 expression may ensure a productive
infectious cycle by prolongation of the survival time of infected
cells. Considering this assumption, a low level of Bcl-2 would
be associated with premature apoptotic cell death and the
inability to sustain HSV replication. If this is true, the decision
point for survival or death exerted by Bcl-2 should be prior to
virus replication. Bcl-2 is known to act at the mitochondrial
level to inhibit the release of cytochrome c into the cytosol.owing HSV-2 infection. Z-VAD-FMK peptide analog of caspase substrates was
OI of 50 PFU/cell, immediately after removing virus inoculum, and at half
yield (right panel) were evaluated in HSV-2-infected untreated cells (HSV-2), in
V-2-infected cells treated with Z-VAD-FMK (HSV-2+Z-VAD-FMK). Apoptosis
howing the nuclear morphology of apoptosis after staining with acridine orange.
essed as mean values±SD obtained from three replicate cultures. For apoptosis,
ni test, was as follows: HSV-2 vs. HSV-2+DMSO, at all times, NS; HSV-2+Z-
SO at 48 h and at 72 h, p<0.001; HSV-2, 24 h vs. 48 h, p=0.013; HSV-2, 24 h
; HSV-2+Z-VAD-FMF, among all times, NS. For virus yield, comparison of
ollows: among the three treatment-groups (HSV-2, HSV-2+DMSO, HSV-2+Z-
8 h vs. 72 h, NS; HSV-2+DMSO, 24 h vs. 48 h and vs. 72 h, p<0.001; HSV-2
0.001; HSV-2+Z-VAD-FMK, 48 h vs. 72 h, NS.
143M.T. Sciortino et al. / Virology 356 (2006) 136–146Cytochrome c release depends on the increased permeability of
the outer mitochondrial membrane, an effect mediated by the
pro-apoptotic Bcl-2 family members Bax and Bak (reviewed in
Borner, 2003; Cory et al., 2003). While it is known that Bcl-2
can somehow inhibit the action of Bax and Bak (although the
exact mechanism is not clear either), it is not yet understood
how Bax and Bak are activated. A third subgroup of the Bcl-2
family, the BH3-only proteins serve as sensors for apoptotic
stimuli which, by unknown mechanisms, convey intracellular
apoptotic signals to the activation of Bax and Bak. It is therefore
possible that HSV-2 activates one of these BH3-only sensor
proteins. During the early phase of infection, high endogenous
Bcl-2 levels would block BH3-only protein-dependent Bax/Bak
activation and cells would be resistant to apoptosis. At later
stages of infection, restricted cells, such as U937 cells, would
undergo apoptosis when Bcl-2 is down-regulated. Conversely,
virus replication would be sustained in permissive cells that
maintain Bcl-2 levels. In any case, the question remains as to
why Bcl-2 levels are down-regulated following HSV-2 infection
in U937 cells, and not in permissive cells. Is this at the
transcriptional or post-transcriptional level and is the down-
regulation a cause or a downstream amplification effect of
apoptosis? Bcl-2 might be cleaved and inactivated by caspases
or other proteases activated during apoptosis. Interestingly,
caspase-dependent Bcl-2 cleavage has been reported to
potentiate apoptosis associated with Bcl-2 down-regulation
(Liang et al., 2002). Particularly, inhibition of caspase activity
during infection by apoptosis-inducing HSV-1 mutant viruses
protected against decreased Bcl-2 levels and apoptosis,
suggesting a caspase-dependent degradation of Bcl-2 protein
during atypical, apoptosis-associated HSV infection (Zachos et
al., 2001). The same study demonstrated that the down-
regulation of Bcl-2 during infection by mutant viruses was
mediated by two additional mechanisms consisting of decreases
in bcl-2 RNA levels and p38MAPK-dependent decreases in the
Bcl-2 protein half-life. Thus, at least in the experimental model
of infection by apoptosis-inducing HSV-1 mutants, it seems that
the decrease in Bcl-2 levels contributes to the amplification of
virus-induced cell death, rather than causes apoptosis in the first
place. If this is the case, another event rather than Bcl-2 down-
regulation must play a role in switching the cell from survival to
apoptosis during the course of HSV-2 infection. This event is
most likely disabled in Bcl-2 overexpressing cells as these cells
become resistant to HSV-2-induced apoptosis.
An alternative possibility is that the control of virus
replication and cell survival by Bcl-2 are separate, even if
interacting, events exerted by different molecular mechanisms.
This is supported by the fact that the survival of fully permissive,
naturally highly Bcl-2-expressing cells, which die by necrosis
after HSV infection, is not longer than that of low-productive
U937 cells that show Bcl-2 down-regulation and die by
apoptosis following HSV infection. Moreover, our results on
HSV-2 gene expression, viral yield and morphologic criteria by
electron microscopy in semi-permissive U937 cells indicate that
restriction in viral replication starts many hours before the
appearance of apoptosis despite the fact that viral genome was
fully expressed. Thus, prolongation of the survival time ininfected cells does not seem to be a major discriminator between
cells producing high or low viral yield. In addition, our results
showing that inhibition of apoptosis by another mechanism,
such as a pan-caspase inhibitor, did not lead to an increased virus
production, indicate that prevention of apoptosis is not sufficient
by itself to overcome the incapacity of U937 cells to fully sustain
HSV-2 replication. Consequently, the augmented permissive-
ness to HSV-2 in Bcl-2 overexpressing cells is not simply related
to the anti-apoptotic action of Bcl-2. Therefore, other mechan-
isms should be considered to understand the relationship
between Bcl-2 expression and permissiveness to HSV-2
infection. Although the major function of Bcl-2 is to protect
cells from apoptosis, other activities have been described. It has,
for example, been demonstrated that bcl-2 gene expression can
result in the inhibition of cell cycle progression at the G1 to S
phase transition leading to a notable retardation of cell
proliferation of several cell lines (Borner, 1996; Mazel et al.,
1996). More recently, a new role for Bcl-2 as a mismatch repair
activity suppressor has been identified (Youn et al., 2005). This
latter function seems to be linked to Bcl-2-dependent cell cycle
regulation, involving the hypophosphorylation of pRb and the
enhancement of the E2F-pRb complex. All these findings
indicate that Bcl-2 expression affects cell cycle progression.
HSV infection is also associated with a block of the cell cycle
and an arrest of host cell growth in the G1 phase (Song et al.,
2000; Ehmann et al., 2000). This phenomenon involves
expression of immediate-early viral proteins and interaction
with cell cycle regulatory cellular proteins. However, the
molecular mechanisms that control cell cycle progression
during HSV infection are not well understood. In fact, they
consist of complex, in some cases apparently contrasting
interplay among viral and cellular factors that can change
depending on multiple variables and cell types. For example,
nuclear expression of cell cycle regulatory proteins cdk2 and
cdk4 seems an essential requirement for HSV-1 productive
reactivation in neurons (Schang et al., 2002) while productive
infection of epithelial cells permissive to HSV-1 causes a block
of cdk4 resulting in cell cycle arrest by decreasing pRb
phosphorylation (Song et al., 2000). Thus, we can hypothesize
that cell cycle regulatory activity exerted by high level Bcl-2
expression may be beneficial for productive infection by HSV-2
in our cellular systems, while down-regulation of the protein
may be detrimental. Moreover, interestingly Bcl-2 localizes not
only to mitochondria but also to the endoplasmic reticulum
(ER), where it regulates the Ca2+ homeostasis (Foyouzi-
Youssefi et al., 2000; Palmer et al., 2004), and to the nuclear
envelope (Lithgow et al., 1994). In particular, it has been
recently shown that phosphorylated Bcl-2 predominantly
localizes to the ER (Bassik et al., 2004). Considering the central
role of these cellular compartments for HSV envelopment and
egress (Roizman and Knipe, 2001; Whiteley, 2001; Leuzinger et
al., 2005), Bcl-2 control of HSV replication could occur also at
this level. Finally, other molecular mechanisms may indepen-
dently contribute to the low level virus production and apoptosis
we observed in our study. Interestingly, it has been reported that
HSV-1 fails to induce SOCS3 and IFN-dependent STAT1
phosphorylation in U937 cells (Yokota et al., 2004), suggesting
144 M.T. Sciortino et al. / Virology 356 (2006) 136–146that low permissiveness of these cells to HSV infection and
induction of apoptosis by HSV in the same cells could be
related, at least in part, to an abnormally efficient IFN response
to HSV.
In summary, we propose that Bcl-2 expression affects HSV-2
replication and hence acts as a major regulator of the
permissiveness state of infected cells. On the other hand,
presumably the virus accurately controls its replication and
spread in different tissues by exerting a tight regulation of Bcl-2
stabilization/degradation. Further studies are necessary to
confirm this hypothesis and to fully understand the role of
Bcl-2 expression in HSV infection.
Materials and methods
Cells and virus
The sources and maintenance of U937 and Vero cells have
been described elsewhere (Medici et al., 2003). U937 human
monocytoid cells expressing the pMEP control vector
(U937pMEP) or the vector containing the murine Bcl-2
(U937Bcl-2), produced for other purposes, have been described
previously (Borner, 1996). They were maintained in culture as
were wild type U937 cells, except for the addition of hygro-
mycin B (50 μg/ml). Preliminary assays showed that these
culture conditions were sufficient to warrant phenotypical and
functional overexpression of the ectopic gene. Cells utilized in
all experiments were derived from aliquots expanded at the
initial passages, kept as frozen stock and used immediately after
thawing and readapting to grow in culture. A “G” strain of HSV-
2, originally provided by Prof. Bernard Roizman, University of
Chicago, was used in these experiments. Virus stocks were
produced and tittered on Vero cells. Infection of U937 cells was
evaluated by means of a microscopy immuno-fluorescence
assay (IFA) using a commercial HSV-2-specific monoclonal
antibody (Kallestad, Sanofi Diagnostic Pasteur, Chaska, MN).
The quantification of infectious viral particles was accom-
plished by a standard plaque assay. Serial dilutions of virus-
containing cell-extracts were added to confluent monolayers of
Vero cells plated in six-well plates and placed in constant
agitation at 37 °C. After 1 h, the inoculum was replaced with
complete medium containing 0.8% (wt/vol) methylcellulose
(Sigma) and incubated for an additional 3 days. The plates were
then stained with 1% (wt/vol) crystal violet in 20% methanol–
80% H2O (vol/vol), and the numbers of plaques were counted.
Titers were calculated as PFU per milliliter of virus suspension.
For experimental infections approximately 5×105 cells/ml were
exposed for 1 h to HSV-2, as previously described (Medici et
al., 2003), at a MOI of 50 PFU/cell. Preliminary experiments
showed that this MOI corresponded to a virus inoculum able to
productively infect about 50–60% of U937 cells, as evaluated
by IFA at 24 h after infection.
Apoptosis assays
Infected and mock-infected U937pMEP and U937Bcl-2
cells were collected by centrifugation at different timesfollowing infection. The percentage of apoptotic cells was
then evaluated using different techniques. Morphological
analysis following staining with acridine orange and flow
cytometry analysis of isolated nuclei stained with propidium
iodide, carried out on a Becton Dickinson FACscalibur using
CELLQuest II software, were performed as previously
described (Mastino et al., 1997).
Antibodies and Western blot analysis
The anti-gD 1103/H170 mAb was kindly provided by Prof.
Bernard Roizman. The anti-human-Bcl-2 fluorescein isothio-
cyanate-conjugated mAb, clone 124, was purchased from Dako.
Western Blot analysis was carried out as previously described
(Medici et al., 2003). After blocking, the blot was incubated
overnight at 4 °C with a mAb to mouse/rat Bcl-2 (clone YTH
10C4, RD System) and incubated with a peroxidase-conjugated
goat anti-mouse IgG (BioSurce). Antibody binding was
detected by chemiluminescence staining using the ECL
detection kit (Amersham Biosciences).
Flow cytometry analysis of gD and Bcl-2 proteins
For double-fluorescence gD/Bcl-2 detection, cells were fixed
in 4% paraformaldehyde in PBS (pH 7.4) for 20 min at room
temperature and permeabilized in 0.1% Triton X-100 in PBS
with 0.1% FCS for 5 min. After washing twice in PBS with 3%
FCS, permeabilized cells were incubated with anti-gD mAb on
ice for 30 min and washed twice in PBS. Cells were then
incubated with a phycoerythrin-conjugated goat anti mouse IgG
(Molecular Probes), as a secondary antibody for gD detection,
for 30 min on ice and washed twice in PBS. Finally, cells were
further incubated with the fluorescein isothiocyanate-conju-
gated anti-human Bcl-2 mAb for 30 min on ice and washed
twice in PBS. Negative control staining consisted of incubation
with the phycoerythrin-conjugated secondary antibody only,
followed by incubation with a fluorescein-conjugated mouse
IgG isotype control (R&D Systems). Stained cells were
acquired and analyzed on a Becton Dickinson FaCScalibur
using CELLQuest II software.
Reverse-transcriptase PCR and relative-quantitative PCR
For reverse-transcriptase PCR, an amount of 106 cells infected
or mock-infected with HSV-2, were collected at different times
post infection and lysed in TRIZOL (GIBCO BRL) to extract total
RNA, according to the manufacturer's instructions. 1.5 μg of total
RNA from U937 cells or 150 ng of total RNA from Vero cells,
respectively, was reverse-transcribed with 60 U of AMV
(Promega) in a total reaction volume of 30 μl. The primer sets
used were: the forward primer, 5′-CGT-GTG-CGA-GCT-GCC-
CTG-TCT-GAA-CGC-3′ and the reverse primer 5′-CGG-AGA-
AAT-GTG-TGG-CCG-CAG-GGA-TAG-3′, located in the US1
gene of HSV-2; the forward primer, 5′-CCA-GTT-CAT-CGC-
GCT-CAT-GCC-CAC-CGC-3′ and the reverse primer 5′-GAC-
GAT-GTT-GTC-GTC-GCC-GGC-GAA-CAC-3′, located in the
UL39 gene of HSV-2; the forward primer, 5′-GGA-ACA-CCG-
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CAG-GAC-GTG-CTT-GTA-AAA-CGC-GGG-CGG -3′, located
in the UL41 gene of HSV-2. Viral DNA of HSV-2 was extracted
as described (Morse et al., 1977) and used as a template for
positive control of the PCR products. The PCR was performed
under the following conditions: 1 min 95 °C, 45 s at 60 °C and
2 min at 72 °C. PCR products were resolved on 2% agarose gel.
Relative-quantitative PCR utilized for the quantitative
analysis of HSV-2 genes expression was performed using the
QuantumRNA 18S internal standards kit, according to the
manufacturer's instructions (Ambion).
Transmission electron microscopy (TEM)
For ultrastructural observation, U937pMEP and U937Bcl-2
cells were fixed with 2.5% glutaraldehyde in 0.1 M MPB
containing 2% sucrose, and then post-fixed with 1% OsO4 in
the same buffer. Cells were then dehydrated in ascending
ethanol concentrations and embedded in Spurr epoxy resin
(Agar Scientific Ltd.). Ultrathin sections were stained with
uranyl acetate and lead citrate and observed under a Philips
CM12 transmission electron microscope (Philips Instruments)
operating at 80 kV.
Caspase-inhibition
For caspase-inhibition experiments, the pan-caspase inhibi-
tor Z-VAD-FMK (Calbiochem), a cell-permeable peptide
analog of caspase substrates, was added to infected and control
cultures at the concentration of 50 μM, immediately after
inoculum removal, and at half concentration daily. Apoptosis
and total virus production were then assayed at different times
by staining with acridine orange and plaque assay on Vero cells,
respectively, as above described.
Statistical analysis
Comparisons of means were carried out using the Student's t
test for independent samples or the Bonferroni multiple
comparison test, where appropriate.
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